Zdrowie i gospodarka · 11/01/2024
FDA Releases Draft Guidance for Reconsideration of Generic Drug User Fee Amendments Requests
The FDA has released a draft guidance for industry on procedures for requesting reconsideration of generic drug applications, updating the 2017 guidance to reflect the latest reauthorization of the Generic Drug User Fee Amendments.